BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 15680247)

  • 1. Expression and spectroscopic characterization of a large fragment of the mu-opioid receptor.
    Kerman A; Ananthanarayanan VS
    Biochim Biophys Acta; 2005 Feb; 1747(1):133-40. PubMed ID: 15680247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biosynthesis, purification, and characterization of a cannabinoid receptor 2 fragment (CB2(271-326)).
    Zhang Y; Xie XQ
    Protein Expr Purif; 2008 Jun; 59(2):249-57. PubMed ID: 18375143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformation of a double-membrane-spanning fragment of a G protein-coupled receptor: effects of hydrophobic environment and pH.
    Kerman A; Ananthanarayanan VS
    Biochim Biophys Acta; 2007 May; 1768(5):1199-210. PubMed ID: 17337264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and biophysical analysis of two double-transmembrane domain-containing fragments from a yeast G protein-coupled receptor.
    Cohen LS; Arshava B; Estephan R; Englander J; Kim H; Hauser M; Zerbe O; Ceruso M; Becker JM; Naider F
    Biopolymers; 2008; 90(2):117-30. PubMed ID: 18260136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of an olfactory receptor in Escherichia coli: purification, reconstitution, and ligand binding.
    Kiefer H; Krieger J; Olszewski JD; Von Heijne G; Prestwich GD; Breer H
    Biochemistry; 1996 Dec; 35(50):16077-84. PubMed ID: 8973178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimized Proteomic Mass Spectrometry Characterization of Recombinant Human μ-Opioid Receptor Functionally Expressed in Pichia pastoris Cell Lines.
    Rosa M; Bech-Serra JJ; Canals F; Zajac JM; Talmont F; Arsequell G; Valencia G
    J Proteome Res; 2015 Aug; 14(8):3162-73. PubMed ID: 26090583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterodimeric CD3epsilongamma extracellular domain fragments: production, purification and structural analysis.
    Kim KS; Sun ZY; Wagner G; Reinherz EL
    J Mol Biol; 2000 Sep; 302(4):899-916. PubMed ID: 10993731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of peptides corresponding to the seven transmembrane domains of human adenosine A2a receptor.
    Lazarova T; Brewin KA; Stoeber K; Robinson CR
    Biochemistry; 2004 Oct; 43(40):12945-54. PubMed ID: 15461468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Refolding, purification, and characterization of a loop deletion mutant of human Bcl-2 from bacterial inclusion bodies.
    Anderson M; Blowers D; Hewitt N; Hedge P; Breeze A; Hampton I; Taylor I
    Protein Expr Purif; 1999 Mar; 15(2):162-70. PubMed ID: 10049671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A transmembrane helix-bundle from G-protein coupled receptor CB2: biosynthesis, purification, and NMR characterization.
    Zheng H; Zhao J; Sheng W; Xie XQ
    Biopolymers; 2006 Sep; 83(1):46-61. PubMed ID: 16634087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The full-length mu-opioid receptor: a conformational study by circular dichroism in trifluoroethanol and membrane-mimetic environments.
    Muller I; Sarramégna V; Renault M; Lafaquière V; Sebai S; Milon A; Talmont F
    J Membr Biol; 2008 May; 223(1):49-57. PubMed ID: 18574543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and spectroscopic analysis of soluble nicotinic acetylcholine receptor fragments derived from the extracellular domain of the alpha-subunit.
    Grant MA; Gentile LN; Shi QL; Pellegrini M; Hawrot E
    Biochemistry; 1999 Aug; 38(33):10730-42. PubMed ID: 10451368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The N-terminal end truncated mu-opioid receptor: from expression to circular dichroism analysis.
    Muller I; Sarramégna V; Milon A; Talmont FJ
    Appl Biochem Biotechnol; 2010 Apr; 160(7):2175-86. PubMed ID: 19636522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure and dynamics of the second and third transmembrane domains of human glycine receptor.
    Ma D; Liu Z; Li L; Tang P; Xu Y
    Biochemistry; 2005 Jun; 44(24):8790-800. PubMed ID: 15952785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A chimeric analysis of the opioid receptor domains critical for the binding selectivity of mu opioid ligands.
    Watson B; Meng F; Akil H
    Neurobiol Dis; 1996 Feb; 3(1):87-96. PubMed ID: 9173916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and purification of functional human mu opioid receptor from E.coli.
    Ma Y; Kubicek J; Labahn J
    PLoS One; 2013; 8(2):e56500. PubMed ID: 23437147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large multiple transmembrane domain fragments of a G protein-coupled receptor: biosynthesis, purification, and biophysical studies.
    Potetinova Z; Tantry S; Cohen LS; Caroccia KE; Arshava B; Becker JM; Naider F
    Biopolymers; 2012; 98(5):485-500. PubMed ID: 23203693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combining a PagP fusion protein system with nickel ion-catalyzed cleavage to produce intrinsically disordered proteins in E. coli.
    Zahran S; Pan JS; Liu PB; Hwang PM
    Protein Expr Purif; 2015 Dec; 116():133-8. PubMed ID: 26297994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and biophysical analysis of a triple-transmembrane domain-containing fragment from a yeast G protein-coupled receptor.
    Caroccia KE; Estephan R; Cohen LS; Arshava B; Hauser M; Zerbe O; Becker JM; Naider F
    Biopolymers; 2011; 96(6):757-71. PubMed ID: 21695690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression, purification and NMR characterization of the cyclic recombinant form of the third intracellular loop of the vasopressin type 2 receptor.
    Bellot G; Pascal R; Mendre C; Urbach S; Mouillac B; Déméné H
    Protein Expr Purif; 2011 Aug; 78(2):131-8. PubMed ID: 21575724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.